UCR medical school develops new curriculum to address substance use crisis
Nearly 6,000 opioid-related overdose deaths occurred in California in 2021, many due to fentanyl, a synthetic opioid. To address the crisis, a team of researchers in the School of Medicine, or SOM, at the University of California, Riverside, plans to develop and implement a curriculum that offers education on substance...
Gift to UCR clinic aims to assist local unhoused population
Funding from San Manuel Band of Mission Indians grants greater medical access to low-income residents
Pandemic led to profound changes in multiple sclerosis clinical practice
UC Riverside-led national survey of MS specialists finds nearly 10% had been redeployed to the front lines of COVID-19 patient care
What UC Riverside scientists have to say about vaccines, variants, and antibodies
Immunity generated by vaccination is better than immunity from an actual infection, says an expert
School of Medicine to serve as lead site for clinical trial on stuttering
Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.
More than half of American adults with advanced multiple sclerosis report mistreatment by caregivers
UC Riverside-led study describes first published survey documenting nature and extent of caregiver mistreatment of this population
Coronavirus lab and testing in place for fall quarter
As the fall quarter begins, UC Riverside has a new diagnostic lab operating on campus that will rapidly process samples from students and employees as part of an ongoing coronavirus testing program. The lab, located at the Multidisciplinary Research Building, or MRB, tested its first sample in August and opened...